About Us
United by a shared purpose, our people combine innovation, expertise and ambition to help take ground breaking science further.
Why Upperton
Accelerating the Development of Better Medicines
Upperton is a UK-based contract development and manufacturing organisation (CDMO) helping pharmaceutical and biotechnology companies transform promising drug candidates into successful medicines.
From early-stage formulation development through to clinical trial supply and commercial manufacturing, we provide integrated development and manufacturing services designed to simplify complex development journeys. Our scientific expertise, regulatory knowledge and flexible approach enable our partners to progress programmes with confidence, speed and quality at every stage.
A Partner for Every Stage of Development
We work with innovators around the world to overcome formulation, analytical and manufacturing challenges across a broad range of drug modalities and dosage forms. Whether supporting a first-in-human study, scaling up a manufacturing process or preparing for commercial launch, our multidisciplinary teams deliver tailored solutions aligned to each programme's unique requirements.
By bringing these capabilities together under one roof, we help reduce complexity, improve communication and create smoother pathways to clinic and commercialisation.
Why Upperton
One site. Fewer handoffs. Better Outcomes.
Our operational structure is tailored to what matters for your business.
We focus on reducing risk, reducing delays and speeding up timelines. These benefits translate into real-world impact: lower total project cost, improved speed to market, and stronger overall programme success.
Where Great Science Goes Further.
Upperton is a leading contract development and manufacturing organisation (CDMO) specialising in delivering flexible, high-quality drug product development and manufacturing solutions for biotech and pharmaceutical innovators.